MedPath

A Prospective, Observational Trial on the Diagnostic and Prognostic of LM

Conditions
Lung Neoplasms
Meningeal Carcinomatosis
Registration Number
NCT02607605
Lead Sponsor
Sun Yat-sen University
Brief Summary

The primary purpose of this study is to compare the positive rate between the cell-free DNA and cytological examination of cerebrospinal fluid in Advanced lung cancer with leptomeningeal metastases.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria
  1. Patient who was confirmed primary lung cancer by pathologic histology or cytology
  2. Adult patients (≥18 years and ≤75 years). ECOG Performance Status 0 or 1.Life expectancy of at least 12 weeks.
  3. Clinical symptoms and imaging tests are highly suspicious of advanced lung cancer with leptomeningeal metastases
  4. Without contraindications to lumbar puncture
Exclusion Criteria
  1. Patients who have primary benign or malignant brain tumor and metastatic malignant brain tumor
  2. Patients who have contraindications to lumbar puncture
  3. Serious uncontrolled systemic disease including active infection,uncontrolled hypertension,diabetes,unstable angina,congestive heart failure,myocardial infarction,severe arrhythmia which needs drugs,hepatic、renal and metabolic disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
positive rate between the cell-free DNA and cytological examination of cerebrospinal fluid2 years
Secondary Outcome Measures
NameTimeMethod
The relationship between the number of cell-free DNA and OS2 years

Trial Locations

Locations (1)

Sun Yat-sen University of cancer center

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath